Novocure Ltd (NVCR)

[doc2016]

tumor treatment fields and quantum computing and transducer array placement?
gemini ai :"is tumor treatment fie?ld fluidic properties related


Yes, the fluidic properties of the body are directly related to the effectiveness and distribution of Tumor Treating Fields (TTFields) and are a key consideration for treatment.

The Role of Body Fluids
TTFields are low-intensity alternating electric fields that are applied externally to the skin. To reach the tumor, these fields must travel through various body tissues, which have different electrical properties. The key fluidic properties that influence this are:

Conductivity: Body fluids, such as cerebrospinal fluid, urine, pleural fluid, and ascites, have much higher electrical conductivity than solid tissues like bone, muscle, and fat. This difference in conductivity greatly influences how the TTFields propagate.

Propagation: The electric fields tend to follow the path of least resistance. Therefore, they will be "channeled" through areas with higher conductivity. This can either intensify the field at the tumor site if the tumor is surrounded by a highly conductive fluid, or attenuate it if the fluid is located in a different area.

Impact on Treatment Planning
Because of this, the fluidic properties of the body are a critical factor in treatment planning.

Computational Modeling: Clinicians use finite element analysis (FEA) to create patient-specific 3D models from MRI and CT scans. These models account for the different electrical properties of various tissues and fluids.

Array Placement: By simulating how the electric fields will propagate through the body's fluids, the models help determine the optimal placement of the transducer arrays on the patient's skin to maximize the field intensity at the tumor site. This personalized approach is crucial because a one-size-fits-all solution would not be effective.

In summary, TTFields do not physically affect the motion of fluids, but the electrical properties of the body's fluids have a significant and measurable impact on the propagation and delivery of TTFields. This relationship is a critical component of how this therapy is planned and administered to patients."